查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1137332

安瓿包装市场 - COVID-19 的增长、趋势、影响和预测（2022-2027 年）

Ampoules Packaging Market - Growth, Trends, and Forecasts (2022 - 2027)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

安瓿包装市场在2021年达到41亿美元，到2027年达到62.7亿美元，在预测期内（2022-2027年）的复合年增长率为7.4%。

包装被认为是製造过程中的关键阶段，增值过程是主要趋势之一。长期以来，製药行业一直使用安瓿瓶，尤其是玻璃瓶作为主要包装解决方案。

主要亮点

  • 政府大力推广仿製药、政府支持设立仿製药分销商、该地区传染病高发等，将导致该地区注射仿製药的增长。预测期。这些是预计会提振市场的一些因素。
  • 塑料安瓿的出现是为了解决安瓿破裂时玻璃颗粒进入内容物的担忧。预计这将为塑料安瓿製造商创造机会，并可能受到各国监管升级和标准的影响。
  • 安瓿瓶的使用在很大程度上受到製药和生命科学最终用户需求的影响，随着需求的变化，市场向这些最终用户倾斜。
  • 负责监督疫苗质量和安全的监管和咨询机构、发达国家和新兴国家的政府、联合采购机构等都是推动全球疫苗市场需求的关键实体。因此，预计近期安瓿产能将获得动力。
  • 在亚太地区，印度等新兴国家的医药市场经历了非凡的增长，SGD Pharma India Ltd. 等公司生产了 4,000 吨管瓶和安瓿瓶（相当于 700 多个SGD Pharma（印度）Vemula 玻璃工厂的百万台），预计市场将显着增长。
  • 同样，安瓿瓶製造商也在进行大量资本投资以在市场上站稳脚跟。例如，Shot AI 将投资 50 卡路里，建立 3.6 亿安瓿的生产能力。
  • 由于全球生产延迟，COVID-19 的传播最初导致供应链中断，从而对市场产生了负面影响。然而，这种情况发生了很大变化。例如，FEVE（欧洲玻璃容器和机械玻璃製造商联合会）敦促当局认识到容器玻璃生产的重要作用，随后领导所有工厂继续生产，为人们提供食品、饮料和药品。

主要市场趋势

塑料安瓿包装占很大份额

  • 製药行业对塑料安瓿的需求正在迅速增长。耐湿性、高尺寸稳定性、高衝击强度、抗变形、低吸水性、透明度、耐热性和阻燃性以及延长的保质期是其在製药行业采用的决定性因素。此外，对低成本封装的高需求也是该行业的主要推动力。
  • 玻璃容器的特点是易碎，我们知道人们担心药物与容器之间的相互作用。这些存储限制正在推动人们对塑料安瓿的兴趣，这些安瓿可以安全地填充、运输、存储和有效剂量，同时符合严格的监管标准。
  • 随着液体配方的增加，对塑料包装的需求也在增加。它们通常是需要极端保护免受外来干扰的优质产品的首选。
  • 液体/半固体给药方式广泛应用于有不同用药需求的儿童。儿童可能难以吞嚥片剂和胶囊，因此他们可能需要较小的剂量。近年来，确保以适合儿童给药的形式获得药物的压力越来越大。
  • 另一方面，与多剂量包装相比，单剂量注射包装越来越成为消费者的选择。塑料安瓿瓶可实现计量剂量，帮助製药公司减少药物过量填充和製造过程效率低下，帮助控製成本。因此，塑料安瓿的使用对于处理昂贵药品的公司特别有利。
  • 例如，根据食品和药物管理局 (FDA) 的规定，在美国，单位剂量塑料安瓿瓶占药品包装的近 24%。预计该行业将为安瓿包装提供高于平均水平的增长机会。

拉丁美洲有望实现显着的长期增长

  • 在拉丁美洲，各国正在积极努力减少向消费者提供的假冒药品、疫苗和药品，从而影响市场的增长。
  • 例如，巴西是该地区最重要的医药市场之一，预计将成为全球重要的参与者。巴西医药市场目前是世界第 6 大市场，预计到 2022 年底将成为世界第 5 大市场。
  • 同样，墨西哥在全球医药市场排名第 11 位。另一方面，阿根廷被认为是该地区的第三大市场。这些医药行业的未来充满希望的国家，对安瓿来说代表着巨大的机遇。
  • 此外，拉丁美洲的老年人口正在迅速增长。 Pharmaphorum 的数据显示，2010 年，该地区 10% 的人口年龄在 60 岁以上，到 2040 年底，这一数字预计将增加一倍以上，达到 21%。超过 80% 的 60 岁以上成年人至少患有一种慢性病，这使得慢性病成为导致人口老龄化的主要原因。

竞争格局

安瓿包装市场是分散的。越来越多的政府举措以及对注射剂和其他药品的需求不断增长，正在为安瓿包装市场创造有利可图的机会。总体而言，现有竞争对手之间的竞争非常激烈。未来，各医药行业大公司的扩张兼併，有望拉动安瓿包装的需求。主要参与者包括 Schott AG、Amposan SA 和 Gerresheimer AG。

  • 2021 年 8 月 - 印度血清研究所，最大的疫苗製造商和生物製剂製造商，购买了印度包装合资企业 SCHOTT Kaisha 50% 的股份。它是德国特种玻璃公司 SCHOTT AG 和印度集团 Kaisha 的合资企业，生产用于包装救生药物的药瓶、注射器、安瓿和药筒等医药包装产品。
  • 2021 年 5 月 - 日本包装公司 Nipro Pharma Packaging 收购了克罗地亚玻璃药品包装製造商 Piramida。在蓝海资本私募股权基金的所有下，Piramida 对其设施进行了现代化改造，安装了 8 条新的生产线，并见证了其安瓿和西林瓶业务的强劲发展。因此，该公司跻身欧洲市场製药行业前五名的安瓿製造商之列。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 3 个月的分析师支持

内容

第一章介绍

  • 研究假设和市场定义
  • 调查范围

第二章研究方法

第 3 章执行摘要

第 4 章市场动态

  • 市场概览
  • 工业吸引力 - 波特五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係
  • 市场驱动力
    • 药品包装防篡改要求
    • 提高可回收玻璃的商业价值
    • 政府法规和标准
  • 市场製约因素
    • 关于倾倒用过的安瓿瓶的担忧
  • COVID-19 对安瓿包装市场的影响

第五章市场动态

  • 市场驱动因素和市场製约因素介绍
  • 市场驱动力
    • 药品包装防篡改需求
    • 政府法规和标准
  • 市场製约因素
    • 关于倾倒用过的安瓿瓶的担忧

第 6 章市场细分

  • 按材料
    • 玻璃
    • 塑料
  • 按最终用户行业
    • 药品
    • 个人护理、化妆品
    • 其他最终用户行业
  • 按地区
  • 北美
    • 最终用户
      • 药品
      • 个人护理、化妆品
      • 其他最终用户行业
    • 国名
      • 美国
      • 加拿大
  • 欧洲
    • 最终用户
      • 药品
      • 个人护理、化妆品
      • 其他最终用户行业
    • 国名
      • 英国
      • 法国
      • 德国
      • 其他欧洲地区
  • 亚太地区
    • 最终用户
      • 药品
      • 个人护理、化妆品
      • 其他最终用户行业
    • 国名
      • 中国
      • 印度
      • 日本
      • 其他亚太地区
  • 拉丁美洲
    • 最终用户
      • 药品
      • 个人护理、化妆品
      • 其他最终用户行业
    • 国名
      • 巴西
      • 墨西哥
      • 其他拉丁美洲地区
  • 中东和非洲
    • 最终用户
      • 药品
      • 个人护理、化妆品
      • 其他最终用户行业
    • 国名
      • 沙特阿拉伯
      • 埃及
      • 其他中东和非洲

第 7 章竞争格局

  • 公司简介
    • Schott AG
    • Gerresheimer AG
    • Stevanato Group
    • ESSCO Glass
    • AAPL Solutions
    • Global Pharmatech Pvt Ltd
    • James
    • Alexander Corporation
    • Nipro Pharma Packaging International NV

第八章投资分析

第 9 章市场潜力

简介目录
Product Code: 51029

The ampoules packaging market was valued at USD 4.1 billion in 2021, and it is expected to reach a value of USD 6.27 billion by 2027 at a CAGR of 7.4%, during the forecast period (2022-2027). Packaging is considered to be a critical stage in the manufacturing process, where the value addition process is one of the significant trends. The pharmaceutical industry has been using ampoules, especially glass, for a very long period, as a primary packaging solution.

Key Highlights

  • The surge in government initiatives to increase the adoption of generic products, government support to start a generic medical store, and a high prevalence of infectious diseases in the region are some factors that are anticipated to boost the generic injectables market in the region, during the forecast period.
  • The emergence of plastic ampoules in the market has been to counter some of the concerns relating to glass particles entering the contents, during the breaking of the ampoules. This is expected to create an opportunity for plastic ampoules manufacturers and may be impacted by regulatory upgrades and standards present in the respective nation.
  • Since the usage of ampoules is profoundly impacted by its demand in the pharmaceutical and life sciences end users, the market remains highly inclined toward these end-users for demand variations.
  • Regulatory and advisory bodies overseeing vaccine quality and safety, governments across industrialized and developing countries, and pooled procurement agencies are some of the leading entities driving the demand for the vaccine market across the world. This is expected to give a boost to ampoule production capacity in the near term.
  • Asia-Pacific may witness significant growth in the market, as developing countries, such as India, witness exceptional growth in a pharmaceutical market where players, like SGD Pharma India Ltd., produces 4,000 metric ton of tubular vials and ampoules annually (corresponding to more than 700 million pieces at the Vemula glassworks of SGD Pharma (India)) to meet the demand for the ampoules in the market.
  • Likewise, manufacturers of ampoules are significantly investing in the capacity to expand their foothold in the market. For instance, Schott AG Kaisha planned to invest INR 50 crores in the plant, to set up a production capacity of 360 million ampoules.
  • The spread of COVID-19 has negatively impacted the market, due to disruptions in the supply chain initially as a result of delayed production, globally. However, the scenario changed significantly. For instance, FEVE (Federation of European manufacturers of glass containers and machine-made glass) called on the authorities to recognize the critical role of container glass manufacturing and subsequently led the manufacturing continuity across all plants to supply people with food, beverages, and pharmaceutical goods.

Key Market Trends

Plastic Ampoules Packaging to Hold a Significant Share

  • Demand for plastic ampoules is witnessing significant growth from the pharmaceutical industry, Features that led to increased pharmaceutical adoption are barrier against moisture, high dimensional stability, high impact strength, resistance to strain, low water absorption, transparency, resistance to heat and flame, and extension of expiry dates.​ Moreover, the high demand for low-cost packaging is another significant driver to the same.
  • Glass containers are characteristically fragile and have been found to cause concerns involving the drug and container interaction. These storage limitations have led to the growing interest in plastic ampoules that can be effectively filled, shipped, stored, and administered safely while following strict regulatory standards.
  • With an increase in liquid dosage forms, the need for plastic packaging is on the rise. These are often the preferred choice for premium products that require extreme protection from foreign particle interference.
  • Liquid/semisolid drug dosages are widely used for children for different medication needs. Children need smaller doses due to difficulty in swallowing tablets or capsules. Over the last few years, there has been increasing pressure to ensure that drugs are available in the form which is suitable for administration to children.​
  • On the other hand, unit dose parenteral packaging as a choice for consumers over multi-dose packaging has been increasing. Plastic ampoules offer fixed dosages that help pharmaceutical companies control costs by reducing drug overfill and inefficiencies in the manufacturing process. Therefore, the use of plastic ampoules is particularly advantageous for companies dealing with costly drugs.
  • For instance, in the United States, as per the Food and Drug Administration (FDA) regulations, unit dose plastic ampoules account for almost 24% for pharmaceutical packaging. The segment is expected to generate above-average growth opportunities to ampoule packaging.

Latin America To Show Significant Growth Over Long Term

  • In Latin America, the market growth is impacted, as the countries are proactively working to reduce these counterfeit medicine, vaccines, and drugs from reaching the consumers.
  • Brazil, for instance, is among the most prominent pharmaceutical markets in the region, with projections estimating it to emerge as a significant player on the global level. Brazil's pharmaceutical business is now positioned as the sixth in the world and is projected to be in the top five, by end of 2022.
  • Similarly, Mexico is globally positioned on 11th rank, on the list of countries in the pharmaceutical market. On the other hand, Argentina is considered the third-largest market in the region. These countries with the promising future of the pharmaceutical industry present a high opportunity for ampoules.
  • Moreover, Latin America's geriatric base is increasing rapidly. In 2010, 10% of the region's population was above 60 years, and by the end of 2040, this number is estimated to more than double, reaching 21%, according to Pharmaphorum. With this increasing aging population, chronic diseases are principally driven, because over 80% of adults aged over 60 years have at least one chronic disease.

Competitive Landscape

The ampoules packaging market is fragmented. The surge in government initiatives, and increasing demand for injectables and other medicines, provide lucrative opportunities in the ampoules packaging market. Overall, the competitive rivalry among existing competitors is high. Moving forward, expansion and mergers of large companies in different pharmaceutical industries are expected to increase the demand of ampoules packaging. Key players are Schott AG, Amposan SA, Gerresheimer AG, etc.

  • August 2021 - Serum Institute of India, the largest vaccine producer and manufacturer of biologics, had bought a 50% stake in the Indian packaging joint venture SCHOTT Kaisha. The joint venture between Germany's specialty glass company SCHOTT AG and Indian group Kaisha, manufactures pharma packaging products such as vials, syringes, ampoules and cartridges used to package life-saving medications.
  • May 2021 - Japan-based packaging company Nipro PharmaPackaging had acquired Croatian glass pharmaceutical packaging manufacturer Piramida. Under the ownership of Blue Sea Capital private equity fund, Piramida got a modernisation of its facilities, welcomed eight new production lines, and witnessed a strong development of its ampoules and vials business. This led the company being ranked among the top five largest ampoule manufacturers for the pharmaceutical industry in the European market.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Industry Attractiveness - Porter's Five Force Analysis
    • 4.2.1 Threat of New Entrants
    • 4.2.2 Bargaining Power of Buyers/Consumers
    • 4.2.3 Bargaining Power of Suppliers
    • 4.2.4 Threat of Substitute Products
    • 4.2.5 Intensity of Competitive Rivalry
  • 4.3 Market Drivers
    • 4.3.1 Demand for Tamper-proof Pharmaceutical Product Packaging
    • 4.3.2 Commodity Value of Glass Increased with Recyclability
    • 4.3.3 Government Regulations and Standards
  • 4.4 Market Restraints
    • 4.4.1 Concerns Regarding Dumping of Used Ampoules
  • 4.5 Impact of the COVID-19 on the Ampoules Packaging Market

5 MARKET DYNAMICS

  • 5.1 Introduction to Market Drivers and Restraints
  • 5.2 Market Drivers
    • 5.2.1 Demand for Tamper-proof Pharmaceutical Product Packaging
    • 5.2.2 Government Regulations and Standards
  • 5.3 Market Restraints
    • 5.3.1 Concerns Regarding Dumping of Used Ampoules

6 MARKET SEGMENTATION

  • 6.1 By Material
    • 6.1.1 Glass
    • 6.1.2 Plastic
  • 6.2 By End-user Industry
    • 6.2.1 Pharmaceutical
    • 6.2.2 Personal Care and Cosmetic
    • 6.2.3 Other End-user Industries
  • 6.3 Geography
  • 6.4 North America
    • 6.4.1 End User
      • 6.4.1.1 Pharmaceutical
      • 6.4.1.2 Personal Care And Cosmetic
      • 6.4.1.3 Other End-user Industries
    • 6.4.2 Country
      • 6.4.2.1 United States
      • 6.4.2.2 Canada
  • 6.5 Europe
    • 6.5.1 End User
      • 6.5.1.1 Pharmaceutical
      • 6.5.1.2 Personal Care And Cosmetic
      • 6.5.1.3 Other End-user Industries
    • 6.5.2 Country
      • 6.5.2.1 United Kingdom
      • 6.5.2.2 France
      • 6.5.2.3 Germany
      • 6.5.2.4 Rest Of Europe
  • 6.6 Asia Pacific
    • 6.6.1 End User
      • 6.6.1.1 Pharmaceutical
      • 6.6.1.2 Personal Care And Cosmetic
      • 6.6.1.3 Other End-user Industries
    • 6.6.2 Country
      • 6.6.2.1 China
      • 6.6.2.2 India
      • 6.6.2.3 Japan
      • 6.6.2.4 Rest Of Asia Pacific
  • 6.7 Latin America
    • 6.7.1 End User
      • 6.7.1.1 Pharmaceutical
      • 6.7.1.2 Personal Care And Cosmetic
      • 6.7.1.3 Other End-user Industries
    • 6.7.2 Country
      • 6.7.2.1 Brazil
      • 6.7.2.2 Mexico
      • 6.7.2.3 Rest Of Latin America
  • 6.8 Middle East and Africa
    • 6.8.1 End User
      • 6.8.1.1 Pharmaceutical
      • 6.8.1.2 Personal Care And Cosmetic
      • 6.8.1.3 Other End-user Industries
    • 6.8.2 Country
      • 6.8.2.1 Saudi Arabia
      • 6.8.2.2 Egypt
      • 6.8.2.3 Rest of Middle East and Africa

7 COMPETITIVE LANDSCAPE

  • 7.1 Company Profiles*
    • 7.1.1 Schott AG
    • 7.1.2 Gerresheimer AG
    • 7.1.3 Stevanato Group
    • 7.1.4 ESSCO Glass
    • 7.1.5 AAPL Solutions
    • 7.1.6 Global Pharmatech Pvt Ltd
    • 7.1.7 James Alexander Corporation
    • 7.1.8 Nipro Pharma Packaging International NV

8 INVESTMENT ANALYSIS

9 FUTURE OF THE MARKET